Clinical Trial Update: A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) [Phase 2]

View source ↗

Summary

This clinical trial update reports that MK-2214-004, a Phase 2 study of MK-2214 in people with early Alzheimer's disease, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• MK-2214

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Early Alzheimer's Disease | Phase 2 | Status: RECRUITING